UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Journal of psychopharmacology (Oxford), 2018-07, Vol.32 (7), p.779-792

2018

Volltextzugriff (PDF)

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Psychopharmacology, 2020-03, Vol.237 (3), p.773-785

2020

Volltextzugriff (PDF)

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects

Journal of psychopharmacology (Oxford), 2022-03, Vol.36 (3), p.309-320

2022

Volltextzugriff (PDF)

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects

Journal of psychoactive drugs, 2020-05, Vol.52 (3), p.273-281

2020

Volltextzugriff (PDF)

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence

Frontiers in psychiatry, 2022-11, Vol.13, p.1049643-1049643

2022

Volltextzugriff (PDF)

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study

Frontiers in psychology, 2018-12, Vol.9, p.2459-2459

2018

Volltextzugriff (PDF)

5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous

Human psychopharmacology, 2022-05, Vol.37 (3), p.e2839-n/a

Lancelotta, Rafael

2022

Volltextzugriff (PDF)

Synthesis and Characterization of 5‑MeO-DMT Succinate for Clinical Use

ACS omega, 2020-12, Vol.5 (49), p.32067-32075

2020

Volltextzugriff (PDF)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Journal of psychoactive drugs, 2020-08, Vol.52 (4), p.289-299

2020

Volltextzugriff (PDF)

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

The American journal of drug and alcohol abuse, 2019-03, Vol.45 (2), p.161-169

2019

Volltextzugriff (PDF)

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

Journal of neurochemistry, 2022-07, Vol.162 (1), p.128-146

2022

Volltextzugriff (PDF)

W160 - Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin

Drug and alcohol dependence, 2024-07, Vol.260

2024

Volltextzugriff (PDF)

Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin

Drug and alcohol dependence, 2024-07, Vol.260, p.110861, Article 110861

2024

Volltextzugriff (PDF)

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes

ACS pharmacology & translational science, 2021-04, Vol.4 (2), p.543-552

2021

Volltextzugriff (PDF)

Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects

Journal of psychedelic studies, 2020-06, Vol.4 (2), p.114-122

2020

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon's predictors and its emotional valence

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study

5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous

Synthesis and Characterization of 5‑MeO-DMT Succinate for Clinical Use

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

W160 - Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin

Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes

Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects

Suchergebnisse filtern